Although not statistically significant ( P =.28), a notable trend was observed: the payer perspective was most commonly applied in pharmacotherapy studies (10/19, 53%), compared with approximately 30% (7/23) in DHIs.
← all excerpts
Comparison of Cost-Effectiveness Between Digital Health Interventions and Pharmacotherapy for Depression: Systematic Review.
1
—
—